Mifepristone in Italy: the case of a drug trapped between ethics and clinical practice
Related Experiment Video
Updated: Jul 16, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Roberto Banfi1, Eleonora Pavone, Rita Cerri
1Pharmacy Department, Azienda USL11 Empoli, 50053 Tuscany, Italy. r.banfi@usl11.toscana.it
In Italy mifepristone is not yet marketed. Gynaecologists in our hospital asked to use this medication as a less traumatic method for voluntary abortions. We followed the standard procedure defined by the Italian Health Ministry (IMH) for purchasing drugs from abroad but encountered several unexpected barriers. Starting from this case, this paper is aimed at identifying these barriers which we found to be not only professional, but also ethical, religious and moral.
In Italy mifepristone is not yet marketed. Gynaecologists in our hospital asked to use this medication as a less traumatic method for voluntary abortions. We followed the standard procedure defined by the Italian Health Ministry (IMH) for purchasing drugs from abroad but encountered several unexpected barriers. Starting from this case, this paper is aimed at identifying these barriers which we found to be not only professional, but also ethical, religious and moral.
Related Concept Videos
Intrauterine Drug Delivery Systems
Drug Regulation
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Drug Control Governance: Regulatory Bodies and Their Impact
Ethical Dilemmas II
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions